chartexchange

FBIOP
Fortress Biotech, Inc. 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock
stockNASDAQPreferred Stock

At CloseNov 17, 2026
0.00USD-100.000%(-13.73)10,646
Loading…
Loading…
Healthcare
Biotechnology
CEO
Lindsay Rosenwald
HQ
Bay Harbor Islands, FL, USA
Previous Close
$13.73
Beta
0.47
52-Week High
$21.43 2026-06-15
52-Week Low
$6.50 2025-11-24
SMA 50
$16.58
SMA 200
$16.40
Avg. Vol 10D
13,350
Avg. Vol 30D
12,823
Avg. Vol 90D
12,366
Relative Vol
0.85
3.43M
14.0000%
148
Jun 14, 2024 · $0.195
FBIOP Profile

fortress biotech, inc. is a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and biotechnology products. fortress plans to develop and commercialize products that it acquires both directly as well as indirectly by establishing subsidiary companies, also known as fortress companies. the company will leverage its biopharmaceutical business expertise and drug development capabilities to help the fortress companies achieve their goals. additionally, the company will provide funding and management services to each of the fortress companies and from time to time the company and the fortress companies will seek licensing, partnerships, joint ventures, and/or public and private financings to accelerate and provide additional funding to support their research and development programs.

FBIOP Performance
PeriodPriceDateChangeBeta
1W15.732026-11-11-11.92%-0.794
1M16.702026-10-19-17.06%0.584
3M18.222026-08-18-23.98%0.712
6M16.102026-05-18-13.97%0.581
1Y6.902025-11-18+100.72%0.468
2Y5.062024-11-18+173.72%—
5Y25.902021-11-18-46.53%0.287
FBIOP Stock Summary

Fortress Biotech, Inc. 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock (NASDAQ:FBIOP) stock price today is $13.85, and today's volume is 10,883. FBIOP is up 0.911% today. The 30 day average volume is 12,823. FBIOP market cap is $47.47M with 3.43M shares outstanding.